Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 8Interventional 3

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 4Breast 3Thoracic 2Other solid neoplasm 2Plasma cell 1Myeloid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 3Cardiotoxicity 2Breast Neoplasms, Male 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Echocardiography × Breast × Clear all
NCT06023576 2026-05-14

A Study of Blood Pressure Control During Cancer Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
130 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT03940625 2022-05-25

ANKE

Heinrich-Heine University, Duesseldorf

Phase NA Completed
69 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡